OCUL in the 13F filings
Ocular Therapeutix Inc · CUSIP 67576A100
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 31
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 3 listed it in both
- Shares listed
- 59,315,194
- combined, among listed positions
- Reported value
- $720m
- combined, at the quarter end
Among the 92 comparable managers: 22 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -2,537,084.
Managers listing OCUL in Q4 2025
31 of 31 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 4,229,202 shares now+2,180,702
- D. E. Shaw & Co.existing position · 1,153,910 shares now+1,040,631
- AllianceBernstein LPexisting position · 4,341,951 shares now+917,512
- Voloridge Investment Management LLCnew position · 812,078 shares now+812,078
- Renaissance Technologies LLCnew position · 791,200 shares now+791,200
Reductions
- Point72 Asset Management LPexisting position · 1,016,248 shares now-3,585,073
- Citadel Advisors LLCexisting position · 2,475,849 shares now-3,227,932
- Balyasny Asset Management LLCexisting position · 763,559 shares now-1,425,717
- Millennium Management LLCexisting position · 3,207,881 shares now-647,825
- Susquehanna International Group LLPexisting position · 10,653 shares now-628,299
New positions and exits
New (7)
Exited (2)
- ExodusPoint Capital Management LPwas $1.9m
- Hudson Bay Capital Management LPwas $585k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2014 | 1 | $14m | n.a. | n.a. |
| Q4 2014 | 1 | $22m | n.a. | n.a. |
| Q1 2015 | 2 | $121m | n.a. | n.a. |
| Q2 2015 | 3 | $107m | n.a. | n.a. |
| Q3 2015 | 3 | $72m | n.a. | n.a. |
| Q4 2015 | 2 | $46m | n.a. | n.a. |
| Q1 2016 | 2 | $47m | n.a. | n.a. |
| Q2 2016 | 1 | $97k | n.a. | n.a. |
| Q3 2016 | 1 | $143k | n.a. | n.a. |
| Q4 2016 | 1 | $1.9m | n.a. | n.a. |
| Q1 2017 | 1 | $1.6m | n.a. | n.a. |
| Q2 2020 | 1 | $289k | n.a. | n.a. |
| Q4 2020 | 2 | $41m | n.a. | n.a. |
| Q1 2021 | 2 | $39m | n.a. | n.a. |
| Q2 2021 | 1 | $17m | n.a. | n.a. |
| Q3 2021 | 1 | $11m | n.a. | n.a. |
| Q1 2023 | 1 | $344k | n.a. | n.a. |
| Q1 2024 | 1 | $9.9m | 1 | 0 |
| Q2 2024 | 1 | $19m | 1 | 0 |
| Q3 2024 | 3 | $36m | 2 | 1 |
| Q4 2024 | 3 | $45m | 3 | 0 |
| Q1 2025 | 2 | $14m | 0 | 2 |
| Q2 2025 | 1 | $9.9m | 0 | 1 |
| Q3 2025 | 3 | $86m | 3 | 0 |
| Q4 2025 | 5 | $88m | 22 | 11 |
| Q1 2026 | 4 | $69m | 19 | 13 |
| Q2 2026 | 1 | $16m | 10 | 20 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
OCUL and LLY →OCUL and JNJ →OCUL and VRTX →Choose a stock to compare with OCUL →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own OCUL, latest filings →Back to the 13F Explorer →